DVAX
Dynavax Technologies Corp
NASDAQ · Biotechnology
$15.50
+0.01 (+0.06%)
Open$15.49
Previous Close$15.49
Day High$15.50
Day Low$15.49
52W High$15.73
52W Low$9.20
Volume—
Avg Volume2.33M
Market Cap1.82B
P/E Ratio—
EPS$-0.38
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
-10.3% upside
Current
$15.50
$15.50
Target
$13.91
$13.91
$9.87
$13.91 avg
$23.13
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 244.15M | 284.66M | 325.64M |
| Net Income | 24.05M | 25.23M | -79,304,400 |
| Profit Margin | 9.9% | 9.4% | -24.4% |
| EBITDA | 4.85M | 5.37M | -97,613,714 |
| Free Cash Flow | — | — | -64,985,684 |
| Rev Growth | -14.2% | -14.2% | +24.6% |
| Debt/Equity | 0.38 | 0.38 | 0.35 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |